🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Several experts said the demand for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Content Removal

According to the social media company, the service has taken down violative material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the service secure and investing in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of joining one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.

Item Information and Pricing

Inside these communities, messages show dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.